表紙
市場調査レポート

EpiCast Report:陰部ヘルペスの疫学的予測 (2023年まで)

EpiCast Report: Genital Herpes - Epidemiology Forecast to 2023

発行 GlobalData 商品コード 337343
出版日 ページ情報 英文 58 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
EpiCast Report:陰部ヘルペスの疫学的予測 (2023年まで) EpiCast Report: Genital Herpes - Epidemiology Forecast to 2023
出版日: 2015年07月10日 ページ情報: 英文 58 Pages
概要

陰部ヘルペスとは慢性の性感染症で、単純ヘルペスウイルス (HSV) により発症します。陰部ヘルペスは母親から新生児にも感染し、感染した乳児が死に至るリスクも高くなっています。単純ヘルペスウイルスにはHSV-1とHSV-2の二種類があり、世界全体で見ればHSV-2の方が有病者数が多いですが、先進国での新規発症件数はHSV-1の方が高くなっています。世界の主要7ヶ国における診断済みの発症件数は、2013年には405,319件、2023年には448,525件に達する見通しで、男性の方が女性よりも発症率が若干低くなっています。

当レポートでは、世界の主要7ヶ国における陰部ヘルペスの発症状況や今後の見通しについて分析し、疾患の特徴(リスク要因や主な共存症など)や世界各国での動向、現在の有病者の発症状況、今後10年間の発症・有病件数 (性別・ウイルス株別) の予測値などを調査・推計しております。

第1章 目次

第2章 イントロダクション

第3章 疫学

  • 疾患の背景
  • リスク要因と共存症
  • 世界的な傾向
  • 予測手法
    • 利用した情報源
    • 利用しなかった情報源
    • 予測の前提条件と手法
  • 陰部ヘルペスの疫学予測(今後11年間分)
    • 診断された発症件数
    • 診断された発症件数 (ウイルス株別)
    • 診断された発症件数 (性別)
    • HSV-1陰部ヘルペスに感染した、と診断の最初の年に診断された患者の数
    • HSV-2陰部ヘルペスに感染した、と診断の最初の年に診断された患者の数
    • 診断された有病者数 (HSV-1のみ)
    • 診断された有病者数 (HSV-2のみ)
    • 診断された有病者数 (HSV-1・HSV-2の双方を併発)
  • 議論
    • 疫学的な予測に関する結論
    • 分析の限界
    • 分析の強み

第4章 付録

図表一覧

目次
Product Code: GDHCER084-15

Genital herpes is a chronic, sexually transmitted infection caused by the herpes simplex virus (HSV) and is the primary cause of genital ulcers. Genital herpes can also be vertically transmitted from a mother to her newborn during birth, leading to a high risk of mortality in infants. HSV has two forms: HSV-1 and HSV-2. The majority of genital herpes cases globally are caused by HSV-2, although approximately half of all new cases in developed countries are caused by HSV-1. Most cases of genital herpes are asymptomatic, leading to the diagnosed prevalence being substantially lower than that of the total prevalence. The symptomatic cases of genital herpes are typically characterized by painful blisters on the genitals and surrounding areas, which normally present between four and seven days after sexual contact with another infected individual.

GlobalData epidemiologists forecast an increase in the diagnosed incident cases of genital herpes in the 7MM from 405,319 in 2013 to 448,525 diagnosed incident cases in 2023, at an Annual Growth Rate (AGR) of 1.07% during the forecast period. The distribution of diagnosed incident cases of genital herpes in the 7MM was lower in men (153,129 cases, 37.78% in 2013) than it was in women (252,190 cases, 62.22% in 2013). The diagnosed prevalent cases of HSV-1 only genital herpes, HSV-2 only genital herpes, and HSV-1 and HSV-2 co-infection genital herpes increased from 2013 to 2023 in the 7MM, with respective AGRs of 0.53%, 0.71%, and 0.74%. In all the markets, the diagnosed prevalent cases of genital herpes increased with age, which is reflective of the lifetime infection characteristic of the disease.

GlobalData's epidemiological forecasts for the diagnosed incident cases and diagnosed prevalent cases of genital herpes are supported by age- and sex-specific data obtained from country-specific studies published in peer-reviewed journals, in which the study populations were representative of the general population in the respective markets. The forecast provides the sex-specific diagnosed incident cases of genital herpes in each of the 7MM and the diagnosed prevalent cases of genital herpes segmented by strain type (HSV-1, HSV-2, and the co-infection of HSV-1 and HSV-2), which facilitate an in-depth understanding of the epidemiological trends and informs strategies to improve the management of the disease.

Scope

  • The Genital Herpes EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for genital herpes in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of genital herpes, segmented by strain (HSV-1 and HSV-2) for ages =18 years, and the diagnosed prevalent cases of HSV-1 only genital herpes, HSV-2 only genital herpes, and genital herpes caused by the co-infection of both HSV-1 and HSV-2, segmented by sex for ages =18 years.
  • The Genital Herpes epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Genital Herpes EpiCast series will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global genital herpes market.
  • Quantify patient populations in the global genital herpes market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for genital herpes therapeutics in each of the markets covered.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Epidemiology

  • 3.1. Disease Background
  • 3.2. Risk Factors and Comorbidities
  • 3.3. Global Trends
  • 3.4. Forecast Methodology
    • 3.4.1. Sources Used
    • 3.4.2. Sources Not Used
    • 3.4.3. Forecast Assumptions and Methods
  • 3.5. Epidemiological Forecast of Genital Herpes (2013-2023)
    • 3.5.1. Diagnosed Incident Cases of Genital Herpes
    • 3.5.2. Diagnosed Incident Cases of Genital Herpes Segmented by Strain
    • 3.5.3. Diagnosed Incident Cases of Genital Herpes Segmented by Sex
    • 3.5.4. Number of Persons Diagnosed with HSV-1 Genital Herpes Experiencing Recurrences During the First Year of Diagnosis
    • 3.5.5. Number of Persons Diagnosed with HSV-2 Genital Herpes Experiencing Recurrences During the First Year of Diagnosis
    • 3.5.6. Diagnosed Prevalent Cases of HSV-1 Only Genital Herpes
    • 3.5.7. Diagnosed Prevalent Cases of HSV-2 Only Genital Herpes
    • 3.5.8. Diagnosed Prevalent Cases of HSV-1 and HSV-2 Co-infection Genital Herpes
  • 3.6. Discussion
    • 3.6.1. Epidemiological Forecast Insight
    • 3.6.2. Limitations of the Analysis
    • 3.6.3. Strengths of the Analysis

4. Appendix

  • 4.1. Bibliography
  • 4.2. About the Authors
    • 4.2.1. Epidemiologists
    • 4.2.2. Reviewers
    • 4.2.3. Global Director of Therapy Analysis and Epidemiology Director of Epidemiology
    • 4.2.4. Global Head of Healthcare
  • 4.3. About GlobalData
  • 4.4. About EpiCast
  • 4.5. Disclaimer

List of Tables

  • Table 1: Risk Factors and Comorbidities for Genital Herpes
  • Table 2: Sources of Epidemiological Data Used for the Forecast of the Diagnosed Incident Cases of Genital Herpes in the 7MM
  • Table 3: Sources of Epidemiological Data Used for the Forecast of the Total Prevalent Cases of HSV-1 Infections in the 7MM
  • Table 4: Sources of Epidemiological Data Used for the Forecast of the Total Prevalent Cases of HSV-2 Genital Herpes in the 7MM
  • Table 5: Sources of Epidemiological Data Used for the Forecast of the Total Prevalent Cases of HSV-1 and HSV-2 Co-infections in the 7MM
  • Table 6: Sources of Epidemiological Data Used for the Forecast of the Diagnosis Rate of HSV-1 Only Genital Herpes in the 7MM
  • Table 7: Sources of Epidemiological Data Used for the Forecast of the Diagnosis Rate of HSV-2 Only Genital Herpes in the 7MM
  • Table 8: Sources of Epidemiological Data Used for the Forecast of the Diagnosis Rate of HSV-1 and HSV-2 Co-infection Genital Herpes in the 7MM
  • Table 9: 7MM, Sources Not Used in the Epidemiological Analysis of Genital Herpes
  • Table 10: 7MM, Diagnosed Incident Cases of Genital Herpes, Both Sexes, Ages ≥18 Years, Select Years 2013-2023
  • Table 11: 7MM, Diagnosed Incident Cases of Genital Herpes Segmented by Strain, Both Sexes, Ages ≥18 Years, 2013
  • Table 12: 7MM, Diagnosed Incident Cases of Genital Herpes Segmented by Sex, Ages ≥18 Years, N (Row %)2013
  • Table 13: 7MM, Number of Persons Diagnosed with HSV-1 Experiencing Recurrences during the First Year of Diagnosis, Both Sexes, Ages ≥18 Years, 2013
  • Table 14: 7MM, Number of Persons Diagnosed with HSV-2 Experiencing Recurrences During the First Year of Diagnosis, Both Sexes, Ages ≥18 Years, 2013
  • Table 15: 7MM, Diagnosed Prevalent Cases of HSV-1 Only Genital Herpes, Both Sexes, Ages ≥18 Years, N, Select Years, 2013-2023
  • Table 16: 7MM, Diagnosed Prevalent Cases of HSV-2 Only Genital Herpes, Both Sexes, Ages ≥18 Years, N, Select Years, 2013-2023
  • Table 17: 7MM, Diagnosed Prevalent Cases of HSV-1 and HSV-2 Co-infection Genital Herpes, Both Sexes, Ages ≥18 Years, Select Years, 2013-2023

List of Figures

  • Figure 1: 7MM, Diagnosed Incident Cases of Genital Herpes, Both Sexes, Ages ≥18 Years, Select Years, 2013-2023
  • Figure 2: Diagnosed incident Cases of Genital Herpes Segmented by Strain, Both Sexes, Ages ≥18 Years, 2013
  • Figure 3: 7MM, Diagnosed Incident Cases of Genital Herpes Segmented by Sex, Ages ≥18 Years, 2013
  • Figure 4: 7MM, Diagnosed Prevalent Cases of HSV-1 Only Genital Herpes, Both Sexes, Ages ≥18 Years, N, 2013-2023
  • Figure 5: 7MM, Diagnosed Prevalent Cases of HSV-2 Only Genital Herpes, Both Sexes, Ages ≥18 Years, N, 2013-2023
  • Figure 6: 7MM, Diagnosed Prevalent Cases of HSV-1 and HSV-2 Co-infection Genital Herpes, Both Sexes, Ages ≥18 Years, Select Years, 2013-2023
Back to Top